VP, Research Governance & Ethics
Sage Bionetworks
Christine Suver, PhD., leads the Research Governance and Ethics group at Sage Bionetworks.
Since 2009, Sage’s Research Governance and Ethics group has developed leading models of legal and ethical solutions, policies, governance processes, and tools to enable open research collaborations, improve research quality and reliability, and empower and protect research participants. The group develops governance for computational analysis contests (DREAM Challenges). It supports large research communities also, like the Accelerating Medicine Partnership for Alzheimer’s Disease (AMP-AD) or the Human Tumor Atlas Network. She also develops new ways to leverage mobile technology to engage and educate people about biomedical research.
Ms. Suver is interested in promoting the FAIR guiding principles for data stewardship and addressing the real-world implication of big data analysis and comprehensive data linkage. For example, she co-developed innovative electronic informed consent (eConsent) for a range of large research initiatives, including the AllofUs Research Program, and has been exploring the real-world implications of using eConsent to support the autonomous decision of populations with a wide range of cognitive abilities.
Ms. Suver co-chair the Governance Working Group of the National COVID Cohort Collaborative initiative (N3C) to enable responsible sharing of clinical data for urgent COVID-related research.
Before joining Sage Bionetworks, she held positions at Lifespan Bioscience and Merck & Co. Inc. Ms. Suver obtained a Master’s in engineering from ENSIA AgroParisTech (France) and a PhD. in Biochemistry from the University of Washington.